Utah Medical Products
UTMD
110 hedge funds and large institutions have $161M invested in Utah Medical Products in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
65% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 26
10% more funds holding
Funds holding: 100 → 110 (+10)
0.72% more ownership
Funds ownership: 68.49% → 69.21% (+0.72%)
0% less capital invested
Capital invested by funds: $162M → $161M (-$690K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$3.4M |
| 2 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$2.36M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.48M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.11M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$797K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.89M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.33M |
| 3 |
BlackRock
New York
|
-$1.14M |
| 4 |
Millennium Management
New York
|
-$940K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$574K |
UTMD Hedge Fund Activity: Q3 2024 in Review
110 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2024, worth a combined $161M — down 0.43% from $162M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new UTMD positions and 9 closed out — a net gain of 10 holders — while 43 added to existing stakes and 26 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $3.4M. The largest seller was Fidelity Investments, cutting an estimated $9.89M.
- 110 institutional investors held Utah Medical Products (UTMD) as of Q3 2024, up from 100 in Q2 2024.
- Funds reported $161M of Utah Medical Products stock for Q3 2024, down 0.43% quarter-over-quarter.
- 19 funds opened new Utah Medical Products positions in Q3 2024 and 9 closed out, a net change of +10 holders.
- The largest Utah Medical Products buyer in Q3 2024 was Hotchkis & Wiley Capital Management, an estimated $3.4M added.
- The largest Utah Medical Products seller in Q3 2024 was Fidelity Investments, an estimated $9.89M sold.
Based on aggregated 13F filings for Q3 2024.